Vir Biotechnology
VIR
VIR
208 hedge funds and large institutions have $901M invested in Vir Biotechnology in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 71 increasing their positions, 67 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $908M → $901M (-$7.64M)
1.3% less ownership
Funds ownership: 67.13% → 65.82% (-1.3%)
Holders
208
Holding in Top 10
2
Calls
$3.04M
Puts
$2.7M
Top Buyers
| 1 | +$9.97M | |
| 2 | +$9.31M | |
| 3 | +$5.77M | |
| 4 |
O
OrbiMed
New York
|
+$5.46M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.75M |
Top Sellers
| 1 | -$27.1M | |
| 2 | -$19.4M | |
| 3 | -$3.27M | |
| 4 |
TC
TwinBeech Capital
Purchase,
New York
|
-$3.22M |
| 5 |
BlackRock
New York
|
-$3.05M |